Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders

Launched by UNIVERSITY HOSPITAL, GRENOBLE · Jun 5, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how much dietary knowledge related to functional insulin therapy (FIT) affects the risk of developing eating disorders in people with type 1 diabetes (T1D). FIT allows individuals to adjust their insulin doses based on what they eat, giving them more flexibility in their diet. However, there are concerns that this increased focus on food and insulin dosing might lead to rigid eating habits, potentially increasing the risk of eating disorders. The researchers want to find out if there is a link between how well someone understands FIT and their risk of having an eating disorder.

To participate in this study, you need to be an adult aged 18 or older with a confirmed diagnosis of type 1 diabetes for at least three months. You also need to have access to a computer or smartphone for online questionnaires and a 45-minute videoconference interview. During the study, participants will answer questions about their knowledge of FIT and their experiences with food, helping researchers understand the relationship between dietary knowledge and eating behaviors. This trial aims to improve patient care by identifying those at risk and tailoring recommendations to better support individuals with T1D.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of type 1 diabetes confirmed by a referring physician
• • Diagnosis received at least three months prior
• • Adult (18 years or older)
• • Access to a computer or smartphone capable of videoconferencing
• • No expressed opposition to participation
• • Consent for image rights (for Phase 2 qualitative interviews)
• Exclusion Criteria:
• • Inability to complete online questionnaires and participate in a 45-minute videoconference interview
• • Being under legal guardianship or curatorship
• • Being pregnant or breastfeeding